KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Issued
Ratios

Abbott Laboratories (ABT) Other Gross PP&E Adjustments (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Other Gross PP&E Adjustments for 17 consecutive years, with -$585.0 million as the latest value for Q4 2025.

  • Quarterly Other Gross PP&E Adjustments fell 6.95% to -$585.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$585.0 million through Dec 2025, down 6.95% year-over-year, with the annual reading at -$585.0 million for FY2025, 6.95% down from the prior year.
  • Other Gross PP&E Adjustments hit -$585.0 million in Q4 2025 for Abbott Laboratories, down from $23.1 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $23.1 billion in Q3 2025 to a low of -$1.2 billion in Q4 2021.
  • Historically, Other Gross PP&E Adjustments has averaged $14.7 billion across 5 years, with a median of $19.0 billion in 2021.
  • Biggest YoY gain for Other Gross PP&E Adjustments was 47.53% in 2022; the steepest drop was 10.3% in 2022.
  • Year by year, Other Gross PP&E Adjustments stood at -$1.2 billion in 2021, then skyrocketed by 47.53% to -$605.0 million in 2022, then rose by 1.98% to -$593.0 million in 2023, then increased by 7.76% to -$547.0 million in 2024, then dropped by 6.95% to -$585.0 million in 2025.
  • Business Quant data shows Other Gross PP&E Adjustments for ABT at -$585.0 million in Q4 2025, $23.1 billion in Q3 2025, and $22.8 billion in Q2 2025.